Patents Assigned to TETRAGON BIOSCIENCE LTD.
  • Deoxy-cytidine or uridine derivatives for use in cancer therapies
    Patent number: 12605397
    Abstract: The present invention relates to a compound of Formula (I): or a stereoisomer, solvate, tautomer or pharmaceutically acceptable salt thereof, wherein X, W1, W2, Y, Z, R1, R2 and R3 are as defined in the disclosure herein, for use in therapy, particularly for use in the treatment of cancer. The present invention also relates to methods of treating cancer comprising the administration of a compound of Formula (I) to a subject in need thereof, and to pharmaceutical compositions and kits comprising such compounds.
    Type: Grant
    Filed: March 12, 2024
    Date of Patent: April 21, 2026
    Assignee: TETRAGON BIOSCIENCE LTD.
    Inventors: Adam Brian Robertson, Terezia Prikrylova